For example, CTLA-4 expressed on tumor-infiltrating Treg cells (TI-Tregs) can bind to CD80/86 with higher affinity than CD28, impairing the maturation of APCs and costimulatory signals to further hinder the activation of anti-tumor CD4+ and CD8+ T cells. This evidence concerns the gene CTLA4 and neoplasm.